目前的景观和初级胆管胆道炎的治疗方法的发展
Stefano Fiorucci1, Ginevra Urbani1, Cristina Di Giorgio1
1Dipartimento di Medicina e Chirurgia, Università di Perugia, 06123 Perugia, Italy.
Cells
|September 27, 2024
概括
初级胆道胆炎 (PBC) 是一种自身免疫性肝脏疾病. 针对胆汁酸和PPAR激动剂的新疗法有望改善治疗结果和个性化患者护理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 初级胆道胆炎 (PBC) 是一种慢性自身免疫性肝脏疾病,导致渐进的胆固醇病.
- 遗传倾向和环境因素有助于PBC的发病,肠道微生物群失生症是潜在的因素.
- 胆管细胞衰老和胆酸失调是PBC进展的关键机制.
研究的目的:
- 审查已发表和正在进行的初级胆管胆道炎 (PBC) 临床试验.
- 检查超越当前基于胆酸的治疗方法的新型治疗方法.
- 讨论新疗法的潜力,如PPAR激动剂在PBC管理中的PPAR激动剂.
主要方法:
- 对临床试验数据和关于PBC治疗的科学文献的审查.
- 对新兴治疗策略的分析,包括elafibranor和seladelpar.
- 探索胆汁酸和胆管细胞衰老在疾病进展中的作用.
主要成果:
- 乌尔索多西胆酸和奥贝西胆酸是已确立的PBC疗法.
- 最近批准的PPAR激动剂 (elafibranor,seladelpar) 代表了新的二线治疗选择.
- 目前正在进行的试验正在评估新的药物来改善PBC治疗.
结论:
- 预计包括PPAR激动剂在内的新疗法将提高PBC治疗效率.
- 在PBC管理中,个性化方法的发展正在推进.
- 对致病机制和治疗点的进一步研究对于改善患者的治疗结果至关重要.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
01:17Chronic Bowel Disorders: Introduction
408
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
408
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
01:30Acute Pancreatitis II: Clinical Manifestations and Management
95
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
95
01:24Chronic Pancreatitis I: Introduction
76
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
76
01:26Diseases of the Liver and Gallbladder
486
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
486